<?xml version="1.0" ?>
<document id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55">
  <chunk id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c0" text="Up-Regulation of Hepatitis C Virus Replication and Production by Inhibition of MEK/ERK Signaling">
    <entity charOffset="17-26" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c0.e0" ontology_id="DOID_2237" text="Hepatitis" type="disease"/>
    <entity charOffset="17-28" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c0.e1" ontology_id="DOID_1883" text="Hepatitis C" type="disease"/>
  </chunk>
  <chunk id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1" text="Background: Viruses interact with and exploit the host cellular machinery for their multiplication and propagation. The MEK/ERK signaling pathway positively regulates replication of many RNA viruses. However, whether and how this signaling pathway affects hepatitis C virus (HCV) replication and production is not well understood.">
    <entity charOffset="138-145" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e0" ontology_id="CHEBI_34922" text="pathway" type="chemical"/>
    <entity charOffset="187-190" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e1" ontology_id="CHEBI_33697" text="RNA" type="chemical"/>
    <entity charOffset="240-247" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e2" ontology_id="CHEBI_34922" text="pathway" type="chemical"/>
    <entity charOffset="256-265" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e3" ontology_id="DOID_2237" text="hepatitis" type="disease"/>
    <entity charOffset="256-267" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e4" ontology_id="DOID_1883" text="hepatitis C" type="disease"/>
    <pair e1="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e0" e2="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e3" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.p0" relation="true"/>
    <pair e1="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e0" e2="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e4" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.p1" relation="true"/>
    <pair e1="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e1" e2="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e3" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.p2" relation="true"/>
    <pair e1="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e1" e2="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e4" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.p3" relation="true"/>
    <pair e1="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e2" e2="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e3" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.p4" relation="true"/>
    <pair e1="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e2" e2="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.e4" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c1.p5" relation="true"/>
  </chunk>
  <chunk id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c2" text="Methods and Results: In this study, we took advantage of two well-characterized MEK/ERK inhibitors and MEK/ERK dominant negative mutants and investigated the roles of the MEK/ERK signaling pathway in HCV gene expression and replication. We showed that inhibition of MEK/ERK signaling enhanced HCV gene expression, plus-and minus-strand RNA synthesis, and virus production. In addition, we showed that this enhancement was independent of interferon-a (IFN-a) antiviral activity and did not require prior activation of the MEK/ERK signaling pathway. Furthermore, we showed that only MEK and ERK-2 but not ERK-1 was involved in HCV replication, likely through regulation of HCV RNA translation.">
    <entity charOffset="80-83" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c2.e0" ontology_id="CHEBI_28398" text="MEK" type="chemical"/>
    <entity charOffset="88-98" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c2.e1" ontology_id="CHEBI_35222" text="inhibitors" type="chemical"/>
    <entity charOffset="103-106" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c2.e2" ontology_id="CHEBI_28398" text="MEK" type="chemical"/>
    <entity charOffset="171-174" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c2.e3" ontology_id="CHEBI_28398" text="MEK" type="chemical"/>
    <entity charOffset="189-196" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c2.e4" ontology_id="CHEBI_34922" text="pathway" type="chemical"/>
    <entity charOffset="266-269" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c2.e5" ontology_id="CHEBI_28398" text="MEK" type="chemical"/>
    <entity charOffset="336-339" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c2.e6" ontology_id="CHEBI_33697" text="RNA" type="chemical"/>
    <entity charOffset="458-467" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c2.e7" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="521-524" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c2.e8" ontology_id="CHEBI_28398" text="MEK" type="chemical"/>
    <entity charOffset="539-546" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c2.e9" ontology_id="CHEBI_34922" text="pathway" type="chemical"/>
    <entity charOffset="581-584" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c2.e10" ontology_id="CHEBI_28398" text="MEK" type="chemical"/>
    <entity charOffset="675-678" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c2.e11" ontology_id="CHEBI_33697" text="RNA" type="chemical"/>
  </chunk>
  <chunk id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3" text="Conclusions: Taken together, these results demonstrate a negative regulatory role of the MEK/ERK signaling pathway in HCV replication and suggest a potential risk in targeting this signaling pathway to treat and prevent neoplastic transformation of HCV-infected liver cells. Citation: Ndjomou J, Park I-w, Liu Y, Mayo LD, He JJ (2009) Up-Regulation of Hepatitis C Virus Replication and Production by Inhibition of MEK/ERK Signaling. PLoS ONE 4(10): e7498.">
    <entity charOffset="77-81" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e0" ontology_id="CHEBI_50906" text="role" type="chemical"/>
    <entity charOffset="107-114" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e1" ontology_id="CHEBI_34922" text="pathway" type="chemical"/>
    <entity charOffset="191-198" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e2" ontology_id="CHEBI_34922" text="pathway" type="chemical"/>
    <entity charOffset="352-361" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e3" ontology_id="DOID_2237" text="Hepatitis" type="disease"/>
    <entity charOffset="352-363" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e4" ontology_id="DOID_1883" text="Hepatitis C" type="disease"/>
    <entity charOffset="438-441" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e5" ontology_id="CHEBI_58972" text="ONE" type="chemical"/>
    <pair e1="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e0" e2="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e3" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.p0" relation="true"/>
    <pair e1="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e0" e2="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e4" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.p1" relation="true"/>
    <pair e1="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e1" e2="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e3" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.p2" relation="true"/>
    <pair e1="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e1" e2="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e4" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.p3" relation="true"/>
    <pair e1="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e2" e2="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e3" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.p4" relation="true"/>
    <pair e1="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e2" e2="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e4" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.p5" relation="true"/>
    <pair e1="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e3" e2="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e5" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.p6" relation="true"/>
    <pair e1="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e4" e2="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.e5" id="82ec1cd41017fab2d523840ae9fb3f30dbeeab55.c3.p7" relation="true"/>
  </chunk>
</document>
